Establishing a core domain set to measure rheumatoid arthritis flares

Report of the OMERACT 11 RA flare workshop

Vivian P. Bykerk, Elisabeth Lie, Susan J. Bartlett, Rieke Alten, Annelies Boonen, Robin Christensen, Daniel E. Furst, Sarah Hewlett, Amye L. Leong, Anne Lyddiatt, Lyn March, James E. May, Pam Montie, Ana-Maria Orbai, Christoph Pohl, Marieke Scholte Voshaar, Thasia Woodworth, Clifton Bingham, Ernest H. Choy

Research output: Contribution to journalArticle

Abstract

Objective. The OMERACT Rheumatoid Arthritis (RA) Flare Group (FG) is developing a data-driven, patient-inclusive, consensus-based RA flare definition for use in clinical trials, longterm observational studies, and clinical practice. At OMERACT 11, we sought endorsement of a proposed core domain set to measure RA flare. Methods. Patient and healthcare professional (HCP) qualitative studies, focus groups, and literature review, followed by patient and HCP Delphi exercises including combined Delphi consensus at Outcome Measures in Rheumatology 10 (OMERACT 10), identified potential domains to measure flare. At OMERACT 11, breakout groups discussed key domains and instruments to measure them, and proposed a research agenda. Patients were active research partners in all focus groups and domain identification activities. Processes for domain selection and patient partner involvement were case studies for OMERACT Filter 2.0 methodology. Results. A pre-meeting combined Delphi exercise for defining flare identified 9 domains as important (> 70% consensus from patients or HCP). Four new patient-reported domains beyond those included in the RA disease activity core set were proposed for inclusion (fatigue, participation, stiffness, and self-management). The RA FG developed preliminary flare questions (PFQ) to measure domains. In combined plenary voting sessions, OMERACT 11 attendees endorsed the proposed RA core set to measure flare with ≧ 78% consensus and the addition of 3 additional domains to the research agenda for OMERACT 12. Conclusion. At OMERACT 11, a core domain set to measure RA flare was ratified and endorsed by attendees. Domain validation aligning with Filter 2.0 is ongoing in new randomized controlled clinical trials and longitudinal observational studies using existing and new instruments including a set of PFQ.

Original languageEnglish (US)
Pages (from-to)799-809
Number of pages11
JournalJournal of Rheumatology
Volume41
Issue number4
DOIs
StatePublished - 2014

Fingerprint

Rheumatoid Arthritis
Education
Consensus
Focus Groups
Delivery of Health Care
Observational Studies
Research
Exercise
Social Identification
Rheumatology
Politics
Self Care
Patient Selection
Fatigue
Longitudinal Studies
Randomized Controlled Trials
Outcome Assessment (Health Care)
Clinical Trials

Keywords

  • Clinical trials
  • Disease activity
  • Flare
  • Omeract filter
  • Outcome and process assessment
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Immunology and Allergy
  • Medicine(all)

Cite this

Bykerk, V. P., Lie, E., Bartlett, S. J., Alten, R., Boonen, A., Christensen, R., ... Choy, E. H. (2014). Establishing a core domain set to measure rheumatoid arthritis flares: Report of the OMERACT 11 RA flare workshop. Journal of Rheumatology, 41(4), 799-809. https://doi.org/10.3899/jrheum.131252

Establishing a core domain set to measure rheumatoid arthritis flares : Report of the OMERACT 11 RA flare workshop. / Bykerk, Vivian P.; Lie, Elisabeth; Bartlett, Susan J.; Alten, Rieke; Boonen, Annelies; Christensen, Robin; Furst, Daniel E.; Hewlett, Sarah; Leong, Amye L.; Lyddiatt, Anne; March, Lyn; May, James E.; Montie, Pam; Orbai, Ana-Maria; Pohl, Christoph; Voshaar, Marieke Scholte; Woodworth, Thasia; Bingham, Clifton; Choy, Ernest H.

In: Journal of Rheumatology, Vol. 41, No. 4, 2014, p. 799-809.

Research output: Contribution to journalArticle

Bykerk, VP, Lie, E, Bartlett, SJ, Alten, R, Boonen, A, Christensen, R, Furst, DE, Hewlett, S, Leong, AL, Lyddiatt, A, March, L, May, JE, Montie, P, Orbai, A-M, Pohl, C, Voshaar, MS, Woodworth, T, Bingham, C & Choy, EH 2014, 'Establishing a core domain set to measure rheumatoid arthritis flares: Report of the OMERACT 11 RA flare workshop', Journal of Rheumatology, vol. 41, no. 4, pp. 799-809. https://doi.org/10.3899/jrheum.131252
Bykerk, Vivian P. ; Lie, Elisabeth ; Bartlett, Susan J. ; Alten, Rieke ; Boonen, Annelies ; Christensen, Robin ; Furst, Daniel E. ; Hewlett, Sarah ; Leong, Amye L. ; Lyddiatt, Anne ; March, Lyn ; May, James E. ; Montie, Pam ; Orbai, Ana-Maria ; Pohl, Christoph ; Voshaar, Marieke Scholte ; Woodworth, Thasia ; Bingham, Clifton ; Choy, Ernest H. / Establishing a core domain set to measure rheumatoid arthritis flares : Report of the OMERACT 11 RA flare workshop. In: Journal of Rheumatology. 2014 ; Vol. 41, No. 4. pp. 799-809.
@article{434ce1b0c7d141a7bd9053cbe0f950a8,
title = "Establishing a core domain set to measure rheumatoid arthritis flares: Report of the OMERACT 11 RA flare workshop",
abstract = "Objective. The OMERACT Rheumatoid Arthritis (RA) Flare Group (FG) is developing a data-driven, patient-inclusive, consensus-based RA flare definition for use in clinical trials, longterm observational studies, and clinical practice. At OMERACT 11, we sought endorsement of a proposed core domain set to measure RA flare. Methods. Patient and healthcare professional (HCP) qualitative studies, focus groups, and literature review, followed by patient and HCP Delphi exercises including combined Delphi consensus at Outcome Measures in Rheumatology 10 (OMERACT 10), identified potential domains to measure flare. At OMERACT 11, breakout groups discussed key domains and instruments to measure them, and proposed a research agenda. Patients were active research partners in all focus groups and domain identification activities. Processes for domain selection and patient partner involvement were case studies for OMERACT Filter 2.0 methodology. Results. A pre-meeting combined Delphi exercise for defining flare identified 9 domains as important (> 70{\%} consensus from patients or HCP). Four new patient-reported domains beyond those included in the RA disease activity core set were proposed for inclusion (fatigue, participation, stiffness, and self-management). The RA FG developed preliminary flare questions (PFQ) to measure domains. In combined plenary voting sessions, OMERACT 11 attendees endorsed the proposed RA core set to measure flare with ≧ 78{\%} consensus and the addition of 3 additional domains to the research agenda for OMERACT 12. Conclusion. At OMERACT 11, a core domain set to measure RA flare was ratified and endorsed by attendees. Domain validation aligning with Filter 2.0 is ongoing in new randomized controlled clinical trials and longitudinal observational studies using existing and new instruments including a set of PFQ.",
keywords = "Clinical trials, Disease activity, Flare, Omeract filter, Outcome and process assessment, Rheumatoid arthritis",
author = "Bykerk, {Vivian P.} and Elisabeth Lie and Bartlett, {Susan J.} and Rieke Alten and Annelies Boonen and Robin Christensen and Furst, {Daniel E.} and Sarah Hewlett and Leong, {Amye L.} and Anne Lyddiatt and Lyn March and May, {James E.} and Pam Montie and Ana-Maria Orbai and Christoph Pohl and Voshaar, {Marieke Scholte} and Thasia Woodworth and Clifton Bingham and Choy, {Ernest H.}",
year = "2014",
doi = "10.3899/jrheum.131252",
language = "English (US)",
volume = "41",
pages = "799--809",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "4",

}

TY - JOUR

T1 - Establishing a core domain set to measure rheumatoid arthritis flares

T2 - Report of the OMERACT 11 RA flare workshop

AU - Bykerk, Vivian P.

AU - Lie, Elisabeth

AU - Bartlett, Susan J.

AU - Alten, Rieke

AU - Boonen, Annelies

AU - Christensen, Robin

AU - Furst, Daniel E.

AU - Hewlett, Sarah

AU - Leong, Amye L.

AU - Lyddiatt, Anne

AU - March, Lyn

AU - May, James E.

AU - Montie, Pam

AU - Orbai, Ana-Maria

AU - Pohl, Christoph

AU - Voshaar, Marieke Scholte

AU - Woodworth, Thasia

AU - Bingham, Clifton

AU - Choy, Ernest H.

PY - 2014

Y1 - 2014

N2 - Objective. The OMERACT Rheumatoid Arthritis (RA) Flare Group (FG) is developing a data-driven, patient-inclusive, consensus-based RA flare definition for use in clinical trials, longterm observational studies, and clinical practice. At OMERACT 11, we sought endorsement of a proposed core domain set to measure RA flare. Methods. Patient and healthcare professional (HCP) qualitative studies, focus groups, and literature review, followed by patient and HCP Delphi exercises including combined Delphi consensus at Outcome Measures in Rheumatology 10 (OMERACT 10), identified potential domains to measure flare. At OMERACT 11, breakout groups discussed key domains and instruments to measure them, and proposed a research agenda. Patients were active research partners in all focus groups and domain identification activities. Processes for domain selection and patient partner involvement were case studies for OMERACT Filter 2.0 methodology. Results. A pre-meeting combined Delphi exercise for defining flare identified 9 domains as important (> 70% consensus from patients or HCP). Four new patient-reported domains beyond those included in the RA disease activity core set were proposed for inclusion (fatigue, participation, stiffness, and self-management). The RA FG developed preliminary flare questions (PFQ) to measure domains. In combined plenary voting sessions, OMERACT 11 attendees endorsed the proposed RA core set to measure flare with ≧ 78% consensus and the addition of 3 additional domains to the research agenda for OMERACT 12. Conclusion. At OMERACT 11, a core domain set to measure RA flare was ratified and endorsed by attendees. Domain validation aligning with Filter 2.0 is ongoing in new randomized controlled clinical trials and longitudinal observational studies using existing and new instruments including a set of PFQ.

AB - Objective. The OMERACT Rheumatoid Arthritis (RA) Flare Group (FG) is developing a data-driven, patient-inclusive, consensus-based RA flare definition for use in clinical trials, longterm observational studies, and clinical practice. At OMERACT 11, we sought endorsement of a proposed core domain set to measure RA flare. Methods. Patient and healthcare professional (HCP) qualitative studies, focus groups, and literature review, followed by patient and HCP Delphi exercises including combined Delphi consensus at Outcome Measures in Rheumatology 10 (OMERACT 10), identified potential domains to measure flare. At OMERACT 11, breakout groups discussed key domains and instruments to measure them, and proposed a research agenda. Patients were active research partners in all focus groups and domain identification activities. Processes for domain selection and patient partner involvement were case studies for OMERACT Filter 2.0 methodology. Results. A pre-meeting combined Delphi exercise for defining flare identified 9 domains as important (> 70% consensus from patients or HCP). Four new patient-reported domains beyond those included in the RA disease activity core set were proposed for inclusion (fatigue, participation, stiffness, and self-management). The RA FG developed preliminary flare questions (PFQ) to measure domains. In combined plenary voting sessions, OMERACT 11 attendees endorsed the proposed RA core set to measure flare with ≧ 78% consensus and the addition of 3 additional domains to the research agenda for OMERACT 12. Conclusion. At OMERACT 11, a core domain set to measure RA flare was ratified and endorsed by attendees. Domain validation aligning with Filter 2.0 is ongoing in new randomized controlled clinical trials and longitudinal observational studies using existing and new instruments including a set of PFQ.

KW - Clinical trials

KW - Disease activity

KW - Flare

KW - Omeract filter

KW - Outcome and process assessment

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=84897405227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897405227&partnerID=8YFLogxK

U2 - 10.3899/jrheum.131252

DO - 10.3899/jrheum.131252

M3 - Article

VL - 41

SP - 799

EP - 809

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 4

ER -